Verlag: Elsevier Science Health Science, 2019
ISBN 10: 0323568025 ISBN 13: 9780323568029
Sprache: Englisch
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 87,28
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 1st edition. 428 pages. 9.00x7.25x1.00 inches. In Stock.
Verlag: Elsevier - Health Sciences Division, 2023
ISBN 10: 0323798330 ISBN 13: 9780323798334
Sprache: Englisch
Anbieter: moluna, Greven, Deutschland
EUR 213,99
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbGebunden. Zustand: New. InhaltsverzeichnisPart One Introduction Ch 1 Evolution of HCT, past, present, and future Ch 2 Human leukocyte antigen Ch 3 Introduction and basic science of chimeric antigen receptor therapies Ch 4 Statisti.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 236,96
Währung umrechnenAnzahl: 3 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Verlag: Elsevier Science Health Science, 2023
ISBN 10: 0323798330 ISBN 13: 9780323798334
Sprache: Englisch
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 230,10
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 1st har/psc edition. 591 pages. 11.00x8.75x1.25 inches. In Stock.
Verlag: Elsevier Health Sciences Mär 2023, 2023
ISBN 10: 0323798330 ISBN 13: 9780323798334
Sprache: Englisch
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
EUR 265,89
Währung umrechnenAnzahl: 2 verfügbar
In den WarenkorbBuch. Zustand: Neu. Neuware - Led by authors from MD Anderson's Stem Cell Transplantation and Cellular Therapy Department, the world's largest and highly respected program at the forefront of rapidly advancing treatments in the field, Manual of Hematopoietic Cell Transplantation and Cellular Therapies is a comprehensive, focused reference covering the latest clinical developments and applications of stem cell transplant and cellular therapies for hematologic malignancies and solid tumors. This cutting-edge title, with a majority contribution from the MD Anderson Cancer Center and leading faculty from other academic institutions, covers breakthrough cell-based therapies for various diseases including lymphoma, multiple myeloma, leukemia, and select solid tumor and autoimmune diseases. This unique, definitive resource is essential for hematologists, fellows in hematology and immunotherapy, mid-level providers, pharmacists, and oncologists who refer patients for cell-based therapies.